In breast cancer, PSMD1 promoted cancer cell growth by inducing p53 protein degradation [30]; PSMD3, in contrast, enhanced cancer cell growth by stabilizing human epidermal growth factor receptor 2 (HER2) from degradation [31]. Here, TP53 is linked to cancer.